TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches

Area of Science:

• Computational chemistry and pharmacology
• Drug discovery and development
• Immunology and molecular biology

Background:

• Computational techniques enhance the analysis of complex biological and chemical data in drug development.
• Big data from empirical and clinical studies are effectively managed using computational approaches.
• Computer-aided drug discovery (CADD) methods are increasingly utilized in pharmaceutical research.

Purpose of the Study:

• To review computational studies and techniques providing insights into Toll-like Receptor 4 (TLR4)-targeting therapeutics.
• To provide an overview of computational methods beneficial for developing novel drugs for TLR-related disorders.
• To highlight the role of TLRs, especially TLR4, as drug targets for inflammatory, autoimmune, and neurodegenerative diseases.

Main Methods:

• Virtual screening
• Pharmacophore modeling
• Quantitative structure-activity relationship (QSAR) analysis
• Molecular docking

Main Results:

• CADD methods have been employed for developing pharmacologically active drugs.
• TLR4 is a validated drug target for numerous diseases, with compounds in clinical evaluation.
• Computational studies have elucidated insights into TLR4-targeting strategies.

Conclusions:

• Computational approaches are crucial for advancing the understanding and development of therapeutics for TLR-related diseases.
• The review offers valuable insights into CADD methods for researchers in the field.
• Novel drug development for inflammatory, autoimmune, and neurodegenerative disorders can be significantly aided by these computational strategies.